CME Presentations

Atopic Dermatitis


Presentations


Speakers

  • Karol Timmons, RN, MS, CPNP

    Karol Timmons, RN, MS, CPNP

    Karol Timmons, RN, MS, CPNP

    Pediatric Nurse Practitioner

    Karol Timmons, RN, MS, CPNP is a pediatric nurse practitioner at Boston Children’s Hospital in Massachusetts, where she specializes in treating children with severe atopic dermatitis and food allergies. She has spent most of her pediatric nursing career at Boston Children’s Hospital and has worked in the Boston Children’s Hospital Allergy/Immunology Program for 24 years. She is the co-founder, with her collaborating physician, of the Boston Children’s Hospital Atopic Dermatitis Center, a multidisciplinary program that includes a pediatric psychologist and pediatric nutritionist. Ms Timmons enjoys working with families to help them manage their disease successfully with education, support, and follow-up. She completed her Master’s degree at Northeastern University in Boston.
  • Corinna Rea, MD, MPH

    Corinna Rea, MD, MPH

    Corinna Rea, MD, MPH

    Instructor

    Corinna Rea, MD, MPH, is an instructor in pediatrics at Harvard Medical School in Boston, Massachusetts, and a pediatrician in the Division of General Pediatrics at Boston Children’s Hospital, where she is also the director of the General Academic Pediatrics Fellowship and the head of faculty development for the Rapid Assessment of Skin Health (RASH) clinic. Dr Rea has a particular interest in dermatology, and created the RASH clinic within primary care at Boston Children’s Hospital to provide services to children with basic dermatologic complaints. She conducts research in the areas of e-consults and referral coordination, quality improvement, and atopic dermatitis. Dr Rea received her medical degree from the Johns Hopkins University School of Medicine in Baltimore, Maryland.
  • Sarina B. Elmariah, MD, PhD

    Sarina B. Elmariah, MD, PhD

    Sarina B. Elmariah, MD, PhD

    Instructor in Dermatology

    Sarina B. Elmariah, MD, PhD, is an instructor in dermatology at Harvard Medical School and a member of the clinical and research faculty at Massachusetts General Hospital in Boston, where she specializes in treating patients with chronic itching and severe inflammatory disorders including refractory atopic dermatitis, psoriasis, allergic skin reactions, and neuropathic and autoimmune skin diseases. She performs basic science and clinical research to understand why people itch and how cutaneous nerves interact with the immune system to influence the development of skin disease. Dr Elmariah has published numerous journal articles, reviews and abstracts, and has authored many online reviews and book chapters. She received her MD and PhD from the University of Pennsylvania School of Medicine.

CME Information

Atopic Dermatitis – Beyond Topical Therapy


LEARNING OBJECTIVES

  • Plan the appropriate level of treatment by assessing the burden of disease associated with AD
  • Identify for whom and when new and emerging targeted therapies apply for patients with AD
  • Incorporate the principles of shared decision-making to the treatment selection, monitoring of disease and treatment outcomes of patients with AD

Acknowledgement

This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals

Tuition

Complimentary

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION STATEMENTS

Live Activity

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)&tade;. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Release/Expiration

Live Activity

Thursday, October 25, 2018 from 11:00am – 12:00pm ET.

Enduring Material

The enduring material will be available from October 25, 2018 to October 25, 2019.

Target Audience

This activity is intended for dermatologists, pediatric dermatologists, primary care physicians, pediatricians, allergists, advanced care practitioners [nurse practitioners (NPs), physician assistants (PAs)], nurses, pharmacists and other health care providers who treat patients with AD.

ESTIMATED TIME TO COMPLETE

This activity consists of one session which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.ImmunologyLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sarina B. Elmariah, MD, PhD Instructor in Dermatology, Harvard Medical School, Dermatologist, Massachusetts General Hospital
Consulting fee: Menlo Therapeutics

Corinna Rea, MD, MPH Instructor in Pediatrics, Harvard Medical School, Director, General Academic Pediatric Fellowship, Boston Children's Hospital
None

Karol Timmons, RN, MS, CPNP Pediatric Nurse Practitioner, Boston Children’s Hospital
Consulting fee: Pfizer NP Advisory Board

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Anne Roc, PhD Senior Medical Director, PlatformQ Health Education, LLC
None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support

Please contact the Postgraduate Institute for Medicine at www.pimed.com.

Technical Support

For any technical issues or issues with your CME Certificate, please contact ImmunologyLive at 877-394-1306 or at Support@ImmunologyLive.com.